- About Us
- Nano-Social Network
- Nano Consulting
- My Account
June 30th, 2005
Jack Uldrich: For years, some of nanotechnology's more enthusiastic boosters have talked about the possibility of "nanobots" coursing through our veins and ridding our bodies of artery-clogging plaques and malignant cancer cells. To help conjure up the possibilities of nanotechnology, the mainstream press often latches onto to the easily digestible -- and much more visually pleasing -- vision of Raquel Welch in Fantastic Voyage being miniaturized and injected into the bloodstream of a prominent scientist to melt a deadly blood clot.
At the risk of incurring the wrath of both nanobot and Raquel Welch fans alike, both scenarios are a ways off, I'm sorry to report. This is not to say that nanotechnology isn't going to play a role in addressing the likes of heart disease, blood clots, and cancer. It is.
|Related News Press|
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Arrowhead Provides Response to New Minority Shareholder Announcement January 7th, 2017